Isis Pharmaceuticals saw its shares drop in the latter part of last week. With few other explanations, it seems plausible that ISIS—the Islamist State of Iraq and al-Sham—has had a negative impact.
from WSJ.com: US Business http://ift.tt/UEAWRg
via IFTTT
from WSJ.com: US Business http://ift.tt/UEAWRg
via IFTTT
No comments:
Post a Comment